There are 2934 resources available
3623 - Phase II Study of Pembrolizumab with Enzalutamide (Enz) in Metastatic, Castration Resistant Prostate Cancer (mCRPC): 30 patient expansion with examination of tumor infiltrating immune cells and fecal microbiota
Presenter: Julie Graff
Session: Poster Discussion – Genitourinary tumours, prostate
Resources:
Abstract
1823 - Preliminary results of a phase I/II dose-escalation study of fractionated dose 177Lu-PSMA-617 for progressive metastatic castration resistant prostate cancer (mCRPC)
Presenter: Scott Tagawa
Session: Poster Discussion – Genitourinary tumours, prostate
Resources:
Abstract
2495 - Docetaxel for hormone-naïve prostate cancer (PCa): results from long-term follow-up of non-metastatic (M0) patients in the STAMPEDE randomised trial (NCT00268476)
Presenter: Nicholas James
Session: Poster Discussion – Genitourinary tumours, prostate
Resources:
Abstract
1199 - Benefit of prostate radiotherapy for patients with lymph node only or < 4 bone metastasis and no visceral metastases: Exploratory analyses of metastatic site and number in the STAMPEDE “M1_RT comparison”
Presenter: Syed Adnan Ali
Session: Poster Discussion – Genitourinary tumours, prostate
Resources:
Abstract
1910 - Patient-Reported Outcomes (PROs) From TITAN: a Phase 3, Randomized, Double-Blind Study of Apalutamide (APA) Versus Placebo (PBO) Added to Androgen Deprivation Therapy (ADT) in Patients (pts) With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Presenter: Neeraj Agarwal
Session: Poster Discussion – Genitourinary tumours, prostate
Resources:
Abstract
Discussion led by Chair
Presenter: Kjell Oeberg
Session: Early diagnosis of neuroendocrine tumours (NETs): Increasing awareness and optimising diagnostic work up
Resources:
Slides
Webcast
5435 - TCR-beta repertoire convergence and evenness are associated with response to immune checkpoint inhibitors
Presenter: Philip Jermann
Session: Poster Discussion 1 – Translational research
Resources:
Abstract
5443 - Harmonization study of Tumour Mutational Burden determination in Non-Small-Cell Lung Cancer (NSCLC)
Presenter: Eva M Garrido-Martin
Session: Poster Discussion 1 – Translational research
Resources:
Abstract
Discussion led by Chair
Presenter: Javier Puente
Session: Specificity of upper tract urothelial carcinoma biology and management
Resources:
Slides
Webcast
Presentation of case/condition
Presenter: John Haanen
Session: Toxicity profiling of immunotherapy of cancer
Resources:
Slides
Webcast